Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Genes and hormones cause hair loss, with four genes contributing equally.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.